Universidad de Alcalá-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

    Breast, Vol. 77

1997

  1. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori

    Scandinavian Journal of Gastroenterology, Vol. 32, Núm. 4, pp. 303-307